Joint Commission International Appoints New Leadership in Key Strategic Region

Food and Healthcare Press Releases Tuesday June 12, 2018 10:17
OAK BROOK, Illinois--12 Jun--PRNewswire/InfoQuest
  • John Yoon Named Managing Director in Asia-Pacific Region

Joint Commission International (JCI) is pleased to announce John Yoon, MBA , as JCI's managing director of the Asia-Pacific Region. In this role, he is responsible for developing relationships between JCI and health care organizations, governments, medical societies and industry clients in their efforts to reduce risk and improve health outcomes.

Yoon joined JCI in January 2017. With more than 13 years of experience in health care and finance, he brings a wealth of knowledge in leading large-scale projects, as well as financial and operational consulting for health care systems and cross-border businesses.

Prior to his role with JCI, Yoon was Philips Healthcare's regional director of Southeast Asia and head of Philips Capital at the Asia-Pacific office in Singapore. In these positions, he led large-scale hospital projects, capital asset financing and turnkey equipment solutions to governments and health care organizations across Asia. He also has managed a multi-specialty spine surgery and rehabilitation hospital as the general manager at Mubadala Development Company in Abu Dhabi, United Arab Emirates, and served as head of international business at Wooridul Spine Hospital in South Korea.

Yoon has worked with leading health care providers in Asia, Europe and the Middle East on strategic partnerships and joint ventures, and led Wooridul's first JCI accreditation. He is an expert in strategic planning, new product launches and project management, which guides his work as new organizations and long-term clients seek accreditation.

"I look forward to continue building relationships and helping our health care partners in the Asia-Pacific Region," Yoon said. "JCI offers various practical solutions to support hospitals and health systems as they make continuous improvement for increased patient safety and quality outcomes. In turn, this builds an organization's standing in the community and often leads to improved financial performance from increased patient satisfaction and referrals."

Yoon takes over the regional leadership role formerly held by Joyce Chang, MHSA, who moved into a newly created position in JCI's U.S. office leading a strategic planning project for the International Accreditation Department. Chang stated she is excited about Yoon's promotion to managing director.

"JCI is very fortunate to have John in this key role," Chang said. "He is a tremendous asset with a proven track record across multiple health care industries and locations."
With more than 323 accredited organizations in 17 countries across the Asia-Pacific Region, Yoon's innovation and creative problem-solving will be an asset to health care organizations throughout the region.
Educational Opportunities

As part of ongoing local education activities, the Asia-Pacific Region offers a monthly webinar series and conferences for health care professionals on quality standards and JCI accreditation. For more information and to register, visit www.jointcommissioninternational.org/ .

Singapore Accreditation Update: 15-16 October 2018
For more information and to register, visit www.jointcommissioninternational.org/singapore-accreditation-update-2018/ .
About Joint Commission International

Joint Commission International (JCI) was established in 1994 as a division of Joint Commission Resources, Inc. (JCR), a wholly controlled, nonprofit affiliate of The Joint Commission. Through international accreditation and certification, advisory services, publications and education programs, JCI extends The Joint Commission's mission worldwide by helping improve the quality of patient care. JCI works with international health care organizations, public health agencies, health ministries and others in more than 100 countries. Visit www.jointcommissioninternational.org for more details.

Media contact:
Katie Looze Bronk
Corporate Communications
(630) 792-5175
kbronk@jointcommission.org
Photo - https://mma.prnewswire.com/media/702404/Joint_Commission_John_Yoon.jpg
Logo - https://mma.prnewswire.com/media/118169/joint_commission_international_logo.jpg

Latest Press Release

Medical Device Manufacturer Advant Medical Celebrates Its 25th Anniversary

Advant is a successful medical device manufacturer with corporate offices located in Galway, Ireland. For a quarter of a century, Advant has seen significant growth and development expanding into two locations in Ireland, Mexico and Costa Rica. With over...

Michel Orsinger Assumes Role as Chairman of Limacorporate#s Advisory Board

LimaCorporate is pleased to announce that Michel Orsinger, Board Member of LimaCorporate's Advisory Board, will assume the role of Chairman of the Board. Michel joined the Advisory Board mid-2017 following a long and successful global career in...

Merck and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer

Merck and Pfizer Inc. (NYSE: PFE) today announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combination with pegylated liposomal doxorubicin (PLD), a type of chemotherapy, compared with PLD did not meet the...

APEC#s Rare Disease Action Plan Sets Precedent to Integrate Rare Disease Care by 2025

- Asia-Pacific Economic Cooperation (APEC) Life Sciences Innovation Forum (LSIF) Rare Disease Network comprises Rare Disease International, Queensland University of Technology and Shire (representing as industry co-chair). - Aims to define, diagnose and...

Grunenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US

Grunenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint to the United States. Averitas Pharma will be commercialising the pain patch Qutenza(R) (8 % capsaicin) for...

Related Topics